Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$8,787,566
+$309,389 QoQ
Shares Held
24,267
+0.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#600
of 3,139 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $22,152,027 across 13 Drug Manufacturers - General names. AMGN ranks #1 (39.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
24,267 | $8,787,566 | |
| 2 | ABBV |
AbbVie Inc.
|
18,850 | $4,743,414 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,544 | $3,924,904 | |
| 4 | JNJ |
Johnson & Johnson
|
11,083 | $2,814,749 | |
| 5 | LLY |
ELI LILLY & Co
|
1,246 | $1,494,489 | |
| 6 | PFE |
Pfizer Inc
|
7,059 | $169,980 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
577 | $72,898 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
800 | $46,096 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,787,566 | 24,267 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $8,478,177 | 24,096 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,947,414 | 24,281 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $7,517,243 | 26,638 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $7,427,265 | 26,601 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $8,300,315 | 26,642 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $6,860,826 | 26,323 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $8,597,207 | 26,682 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $8,157,132 | 26,107 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $7,374,123 | 25,936 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $7,432,356 | 25,805 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $6,983,191 | 25,983 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $5,406,409 | 24,351 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $6,020,783 | 24,905 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $6,588,061 | 25,084 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $5,648,524 | 25,060 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $6,099,044 | 25,068 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $6,046,950 | 25,006 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,633,023 | 25,039 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $5,185,895 | 24,387 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $5,971,143 | 24,497 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $5,149,748 | 22,398 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $5,534,334 | 21,775 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,040,799 | 21,372 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $4,096,362 | 20,206 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||